{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:25:53Z","timestamp":1791429953092,"version":"4.3.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Primary aldosteronism (PA) is a common endocrine cause of secondary hypertension. The aldosterone\/renin ratio is an important tool for PA screening, and dynamic testing in serum or urine is used to confirm the diagnosis. While LC-MS\/MS is considered the gold standard for testing, there is significant interlaboratory variability between the extraction procedures, which can impact diagnostic interpretation. To help overcome this, we present a simple and accurate LC-MS\/MS method for the quantification of both serum and urine aldosterone using a novel enzymatic hydrolysis procedure.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum and urine aldosterone was extracted and measured by LC-MS\/MS. Urine-conjugated aldosterone glucuronide was hydrolyzed using a genetically modified glucuronidase enzyme. The assay precision, accuracy, limit of quantification, recovery, and carryover were evaluated and the new assay cut-offs were proposed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The liquid chromatography method allowed for adequate separation of the aldosterone peak from closely eluting peaks. Significant in vitro aldosterone loss was observed during acid-catalyzed hydrolysis of urine, which was corrected with the addition of the internal standard to the urine before the hydrolysis step. Glucuronidase catalyzed hydrolysis of urine aldosterone glucuronide displays good correlation with the corrected acid-catalyzed hydrolysis. Serum aldosterone showed good agreement with reference values and the consensus range reported for external quality assessment specimens.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A simple, fast, and highly accurate method for the detection of serum and urine aldosterone has been developed. The proposed novel enzymatic procedure allows for short hydrolysis time and compensates for urine aldosterone loss during the hydrolysis step.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/clinchem\/hvad065","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T13:33:27Z","timestamp":1686317607000},"page":"915-923","source":"Crossref","is-referenced-by-count":11,"title":["A Novel Enzymatic Hydrolysis Method for Urine Aldosterone Quantification: A Case for Reassessing Clinical Cut-Offs of Primary Aldosteronism"],"prefix":"10.1093","volume":"69","author":[{"given":"Mehrdad","family":"Yazdanpanah","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, St. Michael\u2019s Hospital , Toronto, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Delaney","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, St. Michael\u2019s Hospital , Toronto, ON , Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto , Toronto, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6113-4008","authenticated-orcid":false,"given":"Daniel R","family":"Beriault","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, St. Michael\u2019s Hospital , Toronto, ON , Canada"},{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto , Toronto, ON , Canada"},{"name":"Li Ka Shing Knowledge Institute, St Michael\u2019s Hospital , Toronto, ON , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"2023080217510685600_hvad065-B1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2023080217510685600_hvad065-B2","first-page":"1","article-title":"Clinical practice guideline for management of primary aldosteronism: what is new in the 2016 update?","volume":"2","author":"Romero","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"2023080217510685600_hvad065-B3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2014a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res"},{"key":"2023080217510685600_hvad065-B4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2015.05.007","article-title":"Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS\/MS","volume":"447","author":"Meunier","year":"2015","journal-title":"Clin Chimica Acta"},{"key":"2023080217510685600_hvad065-B5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00365513.2018.1480060","article-title":"A precise, sensitive and stable LC-MSMS method for detection of picomolar levels of serum aldosterone","volume":"78","author":"Lie","year":"2018","journal-title":"Scandinavian J Clin Lab Invest"},{"key":"2023080217510685600_hvad065-B6","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","article-title":"Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism","volume":"103","author":"Guo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2023080217510685600_hvad065-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2021.122740","article-title":"A liquid chromatography-tandem mass spectrometry (LC-MS\/MS)-based assay for simultaneous quantification of aldosterone, renin activity, and angiotensin II in human plasma","volume":"1179","author":"Chen","year":"2021","journal-title":"J Chromatogr B"},{"key":"2023080217510685600_hvad065-B8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism, implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"2023080217510685600_hvad065-B9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clinbiochem.2015.11.004","article-title":"Sodium interference in the determination of urinary aldosterone","volume":"49","author":"Aldea","year":"2016","journal-title":"Clin Biochem"},{"key":"2023080217510685600_hvad065-B10","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2023080217510685600_hvad065-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.859347","article-title":"Re-assessment of the oral salt loading test using a new chemiluminescent enzyme immunoassay based on a two-step sandwich method to measure 24-hour urine aldosterone excretion","volume":"13","author":"Ozeki","year":"2022","journal-title":"Front Endocrinol"},{"key":"2023080217510685600_hvad065-B12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jchromb.2019.03.012","article-title":"Establishment of a rapid and simple liquid chromatography tandem mass spectrometry method for measuring aldosterone in urine","volume":"1139","author":"Yin","year":"2019","journal-title":"J Chromatogr B"},{"key":"2023080217510685600_hvad065-B13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-3182-8_5","article-title":"Quantitation of aldosterone in serum or plasma using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"1378","author":"Van Der Gugten","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2023080217510685600_hvad065-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.859347","article-title":"Re-assessment of the oral salt loading test using a new chemiluminescent enzyme immunoassay based on a two-step sandwich method to measure 24-hour urine aldosterone excretion","volume":"13","author":"Ozeki","year":"2022","journal-title":"Front Endocrinol"},{"key":"2023080217510685600_hvad065-B15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.2040-1124.2010.00011.x","article-title":"Combination therapy of miglitol and insulin in type 1 diabetes mellitus patients","volume":"1","author":"Kubo","year":"2010","journal-title":"J Diabetes Invest"},{"key":"2023080217510685600_hvad065-B16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bcmd.2013.04.005","article-title":"Miglustat therapy in type 1 Gaucher disease: clinical and safety outcomes in a multicenter retrospective cohort study.","volume":"51","author":"Kuter","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"2023080217510685600_hvad065-B17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2023080217510685600_hvad065-B18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"2023080217510685600_hvad065-B19","first-page":"1","article-title":"Recalibrating interpretations of aldosterone assays across the physiologic range: immunoassay and liquid chromatography\u2013tandem mass spectrometry measurements under multiple controlled conditions","volume":"6","author":"Brown","year":"2022","journal-title":"J Endo Society"},{"key":"2023080217510685600_hvad065-B20","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2023080217510685600_hvad065-B21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00045415-199907000-00012","article-title":"Primary aldosteronism. A common and curable form of hypertension","volume":"7","author":"Young","year":"1999","journal-title":"Cardiol Rev"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/69\/8\/915\/51025733\/hvad065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/clinchem\/article-pdf\/69\/8\/915\/51025733\/hvad065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T17:54:52Z","timestamp":1690998892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/69\/8\/915\/7190226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,6,5]]},"published-print":{"date-parts":[[2023,8,2]]}},"URL":"https:\/\/doi.org\/10.1093\/clinchem\/hvad065","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,8]]},"published":{"date-parts":[[2023,6,5]]}}}